News
Enter your email address to get Core One Labs News Alerts.
News
Enter your email address to get Core One Labs News Alerts.
Company News
European University to Fund Core One Labs’ Akome Advanced Neurogenesis Stimulation Studies
October 14, 2022
Vancouver, British Columbia, Canada – October 14, 2022 – Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD6, WKN: A3CSSU)...
Read more
Company News
Core One Labs Nearing GMP Production as Canada’s Province of Alberta Announces Game Changing Legislation
October 07, 2022
Vancouver, British Columbia, Canada – October 7, 2022 – Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD6, WKN: A3CSSU) (the...
Read more
Company News
Core One Labs Announces Breakthrough with Proprietary Isolation and Purification Method of Psilocybin from Mushrooms; Prepares Patent Application
September 30, 2022
Vancouver, British Columbia, Canada – September 30, 2022 – Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD6,...
Read more
Company News
Core One Labs Signs Letter of Intent with GMP Manufacturing Partner for Production of Proprietary Psychedelic Compounds
September 23, 2022
Vancouver, British Columbia, Canada – September 23, 2022 – Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD6,...
Read more
Company News
Core One Labs’ Akome Move Psychedelic Drug Formulations to Next Stage of Development: Initiating Phase 2 Analysis of Therapeutic Potential
September 16, 2022
Vancouver, British Columbia, Canada – September 16, 2022 – Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD6,...
Read more
Company News
Core One Labs’ Scientists Successfully Complete Breakthrough First Step in Producing API-Grade DMT
September 02, 2022
Second Ground Breaking Technological Advancement
Vancouver, British Columbia, Canada – September 2, 2022 – Core One Labs Inc. (CSE: COOL),...
Read more